Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Genetic Technologies Ltd
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
July 16, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType to Enter Canadian and New Zealand Markets
July 09, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
June 25, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
June 21, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Expands Operational Capacity in North America
June 18, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
June 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
May 29, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType and Humanise Health host “Know Your Risk” Event
May 23, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
May 06, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Appendix 4C & Quarterly Business Update – March 2024
April 30, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
April 22, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Announces $2 Million Registered Direct Offering
April 18, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
April 17, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG to pilot GeneType in Breast Screen centers across the U.S.
April 11, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
April 08, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
April 02, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG Global Collaborations and Innovation Update
March 26, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
March 25, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG to launch U.S. Customer Digital Media Sales Campaign
February 28, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Launching our most comprehensive test and expanding into new global markets
January 31, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
December 14, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
October 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
October 18, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
September 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
September 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
September 11, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
September 01, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.